Benzinga | Mar 23, 2021 07:25AM EDT

B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13

B of A Securities initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral rating and announces Price Target of $13.